Effect of Metabolic Syndrome Score, Metabolic Syndrome, and Its Individual Components on the Prevalence and Severity of Angiographic Coronary Artery Disease

被引:0
作者
Ming-Hui Gui
Yan Ling
Lin Liu
Jing-Jing Jiang
Xiao-Ying Li
Xin Gao
机构
[1] Department of Endocrinology and Metabolism, Shanghai Zhongshan Hospital, Fudan University
[2] Fudan Institute for Metabolic Diseases
关键词
Coronary Angiography; Coronary Artery Disease; Metabolic Syndrome; Metabolic Syndrome Score;
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)]; R589 [代谢病];
学科分类号
1002 ; 100201 ;
摘要
Background: The clinical significance of metabolic syndrome(MS) score, MS, and its individual components with respect to risk prediction of coronary artery disease(CAD) remains unclear. The objective of this study was to investigate whether and to what extent MS score, MS, and its individual components were related to the risk of CAD.Methods: Among 1191 participants who underwent coronary angiography for the confirmation of suspected myocardial ischemia, 858 were included in this study according to the inclusion criteria from September 2010 to June 2013. MS was diagnosed with the 2005 National Cholesterol Education Program Adult Treatment Panel III criteria. The severity of coronary atherosclerosis was assessed by Gensini score.Results: The results showed that the age-and sex-adjusted odds ratios(ORs) for CAD were as follows: MS score, 1.327; MS, 2.013; elevated waist circumference, 1.447; reduced high-density lipoprotein cholesterol, 1.654; and elevated fasting glucose, 1.782; all P < 0.05; whereas for elevated triglycerides, 1.324, and elevated blood pressure, 1.342, both P > 0.05. After multivariate adjustment, results showed that only MS and elevated fasting glucose were significantly associated with CAD(OR, 1.628, 95% confidence interval [CI ], 1.151–2.305, P = 0.006 for elevated fasting glucose, and OR, 1.631, 95% CI, 1.208–2.203, P = 0.001 for MS). The study showed that only MS score and elevated fasting glucose were significantly associated with Gensini score(standardized coefficient, 0.101, P = 0.031 for elevated fasting glucose and standardized coefficient, 0.103, P = 0.009 for MS score).Conclusions: The present study demonstrated that MS score, MS, and its individual components might have different contributions to CAD prevalence and severity. MS and elevated fasting glucose were independent risk factors for the prevalence of angiographic CAD whereas MS score and elevated fasting glucose were significantly associated with the severity of CAD.
引用
收藏
页码:669 / 677
页数:9
相关论文
共 30 条
  • [1] Prevalence of the Metabolic Syndrome Among Employees in Northeast China
    Wang, Xin
    Yang, Fang
    Bots, Michiel L.
    Guo, Wei-Ying
    Zhao, Bing
    Hoes, Arno W.
    Vaartjes, Ilonca
    [J]. CHINESE MEDICAL JOURNAL, 2015, 128 (15) : 1989 - 1993
  • [2] Prevalence of metabolic syndrome and association with burden of atherosclerotic disease in patients with stable coronary artery disease
    Varounis, Christos
    Rallidis, Loukianos S.
    Franco, Oscar H.
    Lekakis, John
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (06) : 1175 - 1181
  • [3] Prevalence of the Metabolic Syndrome Among Employees in Northeast China
    Wang, Xin
    Yang, Fang
    Bots, Michiel L.
    Guo, Wei-Ying
    Zhao, Bing
    Hoes, Arno W.
    Vaartjes, Ilonca
    [J]. CHINESE MEDICAL JOURNAL, 2015, 128 (15) : 1989 - 1993
  • [4] Fasting plasma glucose correlates with angiographic coronary artery disease prevalence and severity in Chinese patients without known diabetes
    Gui, Ming-Hui
    Li, Xiang
    Lu, Zhi-Qiang
    Gao, Xin
    [J]. ACTA DIABETOLOGICA, 2013, 50 (03) : 333 - 340
  • [5] Do Different Metabolic Syndrome Definitions Predict Cerebrovascular Events and Coronary Heart Disease Independent of Their Components? 9 Years Follow-Up of the Tehran Lipid and Glucose Study
    Hadaegh, Farzad
    Mohebi, Reza
    Cheraghi, Leila
    Tohidi, Maryam
    Moghaddam, Nahid Beladi
    Bozorogmanesh, Mohammadreza
    Sheikholeslami, Farhad
    Azizi, Fereidoun
    [J]. STROKE, 2012, 43 (06) : 1669 - 1671
  • [6] The angiographic and clinical outcomes after coronary stenting in patients with metabolic syndrome.[J].Di Xu;Yan Guo;Hui Wang;Bing Gu;Genyan Liu;Chuanwei Zhou;Xin Wu;Junhong Wang;Kejiang Cao.Atherosclerosis.2011, 2
  • [7] Differential Relationship between Metabolic Syndrome Score and Severity of Coronary Atherosclerosis as Assessed by Angiography in a Non-Diabetic and Diabetic Korean Population
    Yoon, Shin-Eui
    Ahn, Sung Gyun
    Kim, Jang-Young
    Park, Jin-Sun
    Shin, Joon-Han
    Tahk, Seung-Jea
    Lee, Su-Kyeong
    Kim, Tae-Jin
    Han, Na
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (07) : 900 - 905
  • [8] Is Prediction of Cardiovascular Disease and All-cause Mortality Genuinely Driven by the Metabolic Syndrome, and Independently from its Component Variables? The Dubbo Study
    Simons, Leon A.
    Simons, Judith
    Friedlander, Yechiel
    McCallum, John
    [J]. HEART LUNG AND CIRCULATION, 2011, 20 (04) : 214 - 219
  • [9] Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes
    Su, Gong
    Mi, Shuhua
    Tao, Hong
    Li, Zhao
    Yang, Hongxia
    Zheng, Hong
    Zhou, Yun
    Ma, Changsheng
    [J]. CARDIOVASCULAR DIABETOLOGY, 2011, 10
  • [10] Impact of Metabolic Syndrome and Its Individual Components on the Presence and Severity of Angiographic Coronary Artery Disease
    Kim, Jong-Youn
    Mun, Hee-Sun
    Lee, Byoung Kwon
    Yoon, Seong Bo
    Choi, Eui-Young
    Min, Pil-Ki
    Yoon, Young-Won
    Hong, Bum-Kee
    Rim, Se-Joong
    Kwon, Hyuck Moon
    [J]. YONSEI MEDICAL JOURNAL, 2010, 51 (05) : 676 - 682